12:00 AM
 | 
Jun 09, 2014
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline neurology, pulmonary news

GlaxoSmithKline has agreed to continue its Patient First Program, which reduces financial incentives for sales representatives to engage in deceptive marketing, at least through March 2019, according to a consent judgment from the...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >